Combinatorial expression of glial transcription factors induces Schwann cell‐specific gene expression in mouse embryonic fibroblasts
Developmental Dynamics · 2025
DOI: 10.1002/dvdy.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Dynamics, 2025. Verfasst von Lauren Belfiore und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Schwann Cells, Fibroblasts, Transcription Factors, Neuroglia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Schwann cells provide peripheral nerve trophic support, myelinate axons, and assist in repair. However, Schwann cell repair capacity is limited by chronic injury, disease, and aging. Schwann cell reprogramming is a cellular conversion strategy that could provide a renewable cell supply to repair injured nerves. Here, we developed a plasmid‐based approach to test the Schwann cell conversion potential of four glial transcription factors.
Results
We employed four transcription factors implicated in Schwann cell differentiation and repair: Sox10, Sox2, Jun, and Pax3. Expression vectors were generated for Sox10 alone and two triple transcription factor combinations: Jun‐Pax3‐Sox2 (triple 1, T1) and Sox10‐Jun‐Sox2 (triple 2, T2). Mouse embryonic fibroblasts (MEFs) were transfected with these vectors, transferred to glial inductive media, and Schwann cell‐marker expression was in assessed by immunostaining, flow cytometry, and qPCR. All expression vectors repressed fibroblast‐specific gene expression. However, T2 was most efficient at generating O4 + Schwann cell‐like cells, which had some capacity to myelinate denervated axons from explanted dorsal root ganglia. In comparison, T1 more efficiently induced repair Schwann cell‐marker expression in converted O4 + cells.
Conclusions
T1 and T2 convert MEFs to Schwann cells with different efficacies and gene expression profiles, and may provide cell‐based therapies for peripheral nerve repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
- Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Carol Schuurmans
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Belfiore, L., Balakrishnan, A., Touahri, Y., Zinyk, D., Noman, H., Okawa, S., Biernaskie, J., & Schuurmans, C. (2025). Combinatorial expression of glial transcription factors induces Schwann cell‐specific gene expression in mouse embryonic fibroblasts. Developmental Dynamics. https://doi.org/10.1002/dvdy.70054
Vancouver
Belfiore L, Balakrishnan A, Touahri Y, Zinyk D, Noman H, Okawa S, et al. Combinatorial expression of glial transcription factors induces Schwann cell‐specific gene expression in mouse embryonic fibroblasts. Developmental Dynamics. 2025. doi:10.1002/dvdy.70054
BibTeX
@article{Belfiore2025,
author = {Belfiore, Lauren and Balakrishnan, Anjali and Touahri, Yacine and Zinyk, Dawn and Noman, Humna and Okawa, Satoshi and Biernaskie, Jeff and Schuurmans, Carol},
title = {Combinatorial expression of glial transcription factors induces Schwann cell‐specific gene expression in mouse embryonic fibroblasts},
journal = {Developmental Dynamics},
year = {2025},
doi = {10.1002/dvdy.70054}
}
EUVIMED